StockTipsArenaBeta

Ajanta Pharma LimitedShare price targets & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹3,513.6+48.80 (+1.41%)
As of 7 Sept 2026
Analysts lean BUY·all 3 long-term calls are BUY·consensus 1Y target ₹4,083.33 (16.2% above CMP)
₹4,083.33
16.2% above CMP
₹3,750 – ₹4,500
3 active 1Y targets
4 open
4 BUY · 0 SELL (all horizons)
68%
21 of 31 closed calls hit
Watch AJANTPHARM for new buy/sell callsGet alertsSee 55 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (35) · loading…

BUYAJANTPHARMAjanta Pharma1 Year
AI4+·0−+0.5% P&L+28.1% upside left
₹3,513.6
CMP
Entry*
₹3,495.9
Target
₹4,500
RBRakesh Bansal· via Zee Business (Live)4w ago
BUYAJANTPHARMAjanta Pharma1 Year
AI4+·0−+2.3% P&L+6.7% upside left
₹3,513.6
CMP
SL
₹3,150
Entry*
₹3,436.2
Target
₹3,750
PHPradeep Haldar, PHD Capital· via Business Today5w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI4+·0−+2.2% P&L+13.8% upside left
₹3,513.6
CMP
Entry*
₹3,436.4
Target
₹4,000
MOMotilal Oswal· via Moneycontrol Broker Research5w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI8+·4−+10.97% realised0.0% upside left
Entry*
₹3,361.2
Target
₹3,730
hit 17 Aug 2026, 12:08 pm
PLPrabhudas Lilladher· via Moneycontrol Broker Research5w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+9.81% realised0.0% upside left
Entry*
₹3,096.3
Target
₹3,400
hit 29 Jun 2026, 12:06 pm
PLPrabhudas Lilladher· via Institutional / Brokerage Research17w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI3+·0−+13.68% realised0.0% upside left
Entry*
₹3,096.3
Target
₹3,520
hit 21 Jul 2026, 12:07 pm
ISICICI Securities· via Institutional / Brokerage Research17w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+8.10% realised0.0% upside left
Entry*
₹3,096.3
Target
₹3,347
hit 29 Jun 2026, 12:06 pm
BCBOB Capital Markets· via Institutional / Brokerage Research17w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+17.34% realised0.0% upside left
Entry*
₹2,897.6
Target
₹3,400
hit 29 Jun 2026, 12:06 pm
MOMotilal Oswal· via Institutional / Brokerage Research17w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+16.49% realised0.0% upside left
Entry*
₹2,807
Target
₹3,270
hit 14 May 2026, 12:05 pm
ISICICI Securities· via Institutional / Brokerage Research31w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+22.22% realised0.0% upside left
Entry*
₹2,781.9
Target
₹3,400
hit 29 Jun 2026, 12:06 pm
MOMotilal Oswal· via Institutional / Brokerage Research31w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+16.91% realised0.0% upside left
Entry*
₹2,690.2
Target
₹3,145
hit 12 Mar 2026, 12:03 pm
MOMotilal Oswal· via Institutional / Brokerage Research36w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+14.91% realised0.0% upside left
Entry*
₹2,610.7
Target
₹3,000
hit 2 Jan 2026, 12:01 pm
ISICICI Securities· via Institutional / Brokerage Research43w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+18.14% realised0.0% upside left
Entry*
₹2,539.4
Target
₹3,000
hit 2 Jan 2026, 12:01 pm
MOMotilal Oswal· via Institutional / Brokerage Research44w ago
SELLAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+6.93% realised0.0% upside left
Target
₹2,500
Entry*
₹2,686.1
hit 6 May 2025, 12:05 pm
ISICICI Securities· via Institutional / Brokerage Research70w ago
SELLAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+9.51% realised0.0% upside left
Target
₹2,528
Entry*
₹2,793.7
hit 11 Feb 2025, 12:00 am
BCBOB Capital Markets· via Institutional / Brokerage Research90w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·1−+17.44% realised0.0% upside left
Entry*
₹2,695.1
Target
₹3,165
hit 13 Aug 2024, 12:08 pm
ISICICI Securities· via Institutional / Brokerage Research109w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·1−+15.98% realised0.0% upside left
Entry*
₹2,530.55
Target
₹2,935
hit 7 Aug 2024, 12:08 pm
MOMotilal Oswal· via Institutional / Brokerage Research109w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·1−+8.44% realised0.0% upside left
Entry*
₹2,383.85
Target
₹2,585
hit 31 Jul 2024, 12:07 pm
BCBOB Capital Markets· via Institutional / Brokerage Research122w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·1−+20.60% realised0.0% upside left
Entry*
₹2,383.85
Target
₹2,875
hit 6 Aug 2024, 12:08 pm
ISICICI Securities· via Institutional / Brokerage Research122w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·1−+14.82% realised0.0% upside left
Entry*
₹2,234
Target
₹2,565
hit 30 Jul 2024, 12:07 pm
MOMotilal Oswal· via Institutional / Brokerage Research122w ago
SELLAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
-3.25% realisedNA upside left
₹2,781.9
At expiry
Target
₹2,288
Entry*
₹2,694.45
expired 30 Jan 2026, 3:30 pm
BCBOB Capital Markets· via Institutional / Brokerage Research83w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
+3.92% realisedNA upside left
₹2,781.9
At expiry
Entry*
₹2,676.85
Target
₹3,220
expired 30 Jan 2026, 3:30 pm
MOMotilal Oswal· via Institutional / Brokerage Research83w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·1−-9.79% realisedNA upside left
₹2,577.6
At expiry
Entry*
₹2,857.3
Target
₹3,455
expired 11 Nov 2025, 3:30 pm
ISICICI Securities· via Institutional / Brokerage Research95w ago
BUYAJANTPHARMAjanta Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·1−-18.28% realisedNA upside left
₹2,388.4
At expiry
Entry*
₹2,922.6
Target
₹3,470
expired 28 Oct 2025, 3:30 pm
MOMotilal Oswal· via Institutional / Brokerage Research97w ago
BUYAJANTPHARMAjanta Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)
AI2+·1−+4.1% P&L+9.0% upside left
₹3,513.6
CMP
Entry*
₹3,374
Target
₹3,829
SSSystematix Shares & Stock· via Economic Times New Stock Recos9w ago
BUYAJANTPHARMAjanta Pharma1–3 MonthsTarget hit
AI7+·5−+16.11% realised0.0% upside left
SL
₹2,100
Entry*
₹3,100.4
Target
₹3,600
hit 13 Aug 2026, 12:08 pm
KJKiran Jani, Jainam Broking· via Business Today14w ago
BUYAJANTPHARMAjanta Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI5+·5−+3.29% realised0.0% upside left
Entry*
₹3,485.5
Target
₹3,600
hit 13 Aug 2026, 9:35 am
RGRatnesh Goyel, Arihant Capital Markets· via Business Today5w ago
BUYAJANTPHARMAjanta Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
+2.83% realised0.0% upside left
SL
₹3,000
Entry
₹3,180
Target
₹3,270
hit 14 May 2026, 3:20 pm
KBKush Bohra· via NDTV Profit16w ago
BUYAJANTPHARMAjanta Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
+7.07% realised0.0% upside left
SL
₹2,980
Entry*
₹3,082.2
Target
₹3,300
hit 19 May 2026, 1:05 pm
SMSomil Mehta, Sharekhan· via CNBC Awaaz.17w ago
BUYAJANTPHARMAjanta Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI3+·3−-2.74% realisedNA upside left
SL
₹3,590
Entry*
₹3,691.1
Target
₹3,860
hit 24 Aug 2026, 9:20 am
KBKush Bohra· via NDTV Profit (Live)3w ago
BUYAJANTPHARMAjanta Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI3+·3−-2.79% realisedNA upside left
SL
₹3,520
Entry*
₹3,620.9
Target
₹3,860
hit 25 Aug 2026, 9:25 am
KBKush Bohra· via NDTV Profit (Live)3w ago
BUYAJANTPHARMAjanta Pharma1–2 WeeksStop-loss hit
-1.18% realisedNA upside left
SL
₹3,170
Entry
₹3,208
Target
₹3,300
hit 23 Jun 2026, 3:15 pm
RSRajesh Satpute· via CNBC Awaaz.10w ago
BUYAJANTPHARMAjanta Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
+0.05% realisedNA upside left
₹3,081.6
At expiry
SL
₹3,040
Entry
₹3,080
Target
₹3,480
expired 25 May 2026, 3:30 pm
OMOm Mehra, SAMCO Securities· via CNBC Awaaz.16w ago
BUYAJANTPHARMAjanta PharmaBTSTExpired
AI3+·1−+0.82% realisedNA upside left
₹3,680
At expiry
SL
₹3,539
Entry*
₹3,650
Target
₹3,760
expired 14 Aug 2026, 3:20 pm
AJAastha Jain, Hem Securities· via Zee Business (Live)3w ago
BUYAJANTPHARMAjanta PharmaIntraday* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-1.13% realisedNA upside left
₹3,615
At expiry
SL
₹3,539
Entry*
₹3,656.3
Target
₹3,700
expired 13 Aug 2026, 3:20 pm
AJAastha Jain, Hem Securities· via Zee Business (Live)3w ago
StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.